Thalia Therapeutics Plc carries a market capitalization of 5.41M, placing it among publicly traded companies globally.
| Market Cap | 5.41M |
| Enterprise Value | N/A |
Thalia Therapeutics Plc's stock has gained approximately 73.33333% over the past 52 weeks. The 50-day moving average sits at 0.61, while the 200-day moving average is 0.56.
| Beta (5Y) | N/A |
| 52-Week Price Change | 73.33333% |
| 50-Day Moving Average | 0.61 |
| 200-Day Moving Average | 0.56 |
| Average Volume (20 Days) | N/A |
Thalia Therapeutics Plc's most recent stock split took place on May 3, 2017 with a 4:1 split ratio.
| Last Split Date | 5/3/2017 |
| Split Ratio | 4:1 |